I NUK3D U
Bluelighter
Could it have something to do with intracranial pressure; and the release thereof?
N&PD Moderators: Skorpio | someguyontheinternet
Do you have links to any research demonstrating that the mechanism of opioid induced nausea is dopaminergic? I have a good many friends who are stimulant enthusiasts, who handle high doses well, exhibiting marked euphoria and compulsive behaivor while lacking nausea, but who experience severe nausea from opioids accompanied by little euphoria.
ebola
Ketamine and Methoxetamine are both dopamine releasers yahh
First Human Evidence of d-Amphetamine Induced Displacement of a D2/3 Agonist Radioligand: A [11C]-( + )-PHNO Positron Emission Tomography Study
Imaging the competition between D2/3 radioligands and endogenous dopamine is so far the only way to measure dopamine release in the living human brain. The dopamine D2 receptor exists in a high (D2 high) and a low-affinity state for dopamine. Under physiological conditions, dopamine is expected to bind to D2 high only. [11C]-( + )-4-propyl-9-hydroxynaphthoxazine (( + )-PHNO) is the first D2/3 agonist radioligand for positron emission tomography (PET) imaging in humans. Since [11C]-( + )-PHNO is expected to bind preferentially to D2 high, it should be particularly vulnerable to competition with endogenous dopamine. Nine healthy subjects participated in two PET scans, one after administration of d-amphetamine and one after placebo. [11C]-( + )-PHNO PET test re-test variability was determined in 11 healthy subjects. Binding potentials (BPs) were calculated for caudate, putamen, ventral striatum, and globus pallidus. d-Amphetamine led to a significant decrease of [11C]-( + )-PHNO BPs in caudate (13.2%), putamen (20.8%), and ventral striatum (24.9%), but not in globus pallidus (6.5%). d-Amphetamine-induced displacement correlated with serum d-amphetamine levels in all regions but caudate. This is the first report on competition between endogenous dopamine and a D2/3 agonist radioligand in humans. [11C]-( + )-PHNO PET might be a superior measure for release of endogenous dopamine than PET employing conventional D2/3 antagonist radioligands.